Virpax Pharmaceuticals, Inc. (VRPX) Reports Q1 Loss of $0.13
Tweet
Share
E-mailGet Alerts VRPX Hot Sheet
Join SI Premium – FREE
Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) reported Q1 EPS of ($0.13), versus $0.00 reported last year.
For earnings history and earnings-related data on Virpax Pharmaceuticals, Inc. (VRPX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Lindsay (LNN) Tops Q3 EPS by 18c, Misses on Revenue
- SWBI beats estimates by 71%, GEO nears 52-week high on policy tailwinds
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
